Mail icon

Using SBV to eradicate the risk of contamination

6 December, 2020 | ChargePoint Technology

As new biological therapies continue to be developed, the market has seen an increased need for innovation. Demand has grown for improved operational efficiency and achieving greater quality and cost reductions in manufacturing processes.

 

In an article with International Biopharmaceutical Industry, Christian Dunne, our Head of Sterile Solutions, discussed split butterfly valve (SBV) technology as an effective containment and powder handling strategy in biologics manufacturing.

 

For full article, click here

Related articles